Have you ever found yourself drowning in repetitive Excel data entry tasks, wishing there was a way to make the process faster, easier, and less prone to errors? Whether you’re managing team schedules ...
It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of Corcept Therapeutics Incorporated CORT skyrocketed after a late-stage study met ...
Exelixis EXEL announced encouraging results from an expansion cohort of the early to mid-stage study of its next-generation oral TKI, zanzalintinib, in combination with either Bristol Myers' BMY ...
Shares of Exelixis, Inc. EXEL gained 7.4% on June 23, after the company announced positive top-line results from the late-stage STELLAR-303 study. This phase III study is a global, multicenter, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback